BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started.
BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies.
Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
Key numbers of this edition can be summed up in 1.300 delegates coming from 900 organizations, 35 countries represented, 100 exhibitors and more than 35 one-to-one meetings per participant.